Founded in 1994, Pharmaniaga Berhad has grown to become one of Malaysia’s leading integrated pharmaceutical groups. The company’s operations encompass the entire pharmaceutical value chain, including research and development, manufacturing of generic drugs and over-the-counter medicines, as well as logistics, distribution, sales, and marketing.
Pharmaniaga’s manufacturing capabilities are extensive, with facilities producing a wide range of pharmaceutical forms such as oral solids, liquids, creams, and small volume injectables. Their product portfolio covers various therapeutic areas, including cardiovascular health, diabetes management, anti-infectives, pain management, and respiratory treatments.
The company also has a significant presence in Indonesia through its subsidiaries, PT Errita Pharma and PT Millennium Pharmacon International Tbk (MPI). MPI is a publicly listed company on the Indonesian Stock Exchange, operating 35 branches nationwide, while Errita Pharma produces over 60 generic pharmaceutical products and over-the-counter medications.
With a workforce exceeding 3,400 employees, including more than 200 scientific and technical experts, Pharmaniaga is dedicated to delivering high-quality pharmaceutical products and services. The company’s commitment to excellence plays a crucial role in enhancing the health and well-being of the communities it serves.
EN
